Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics

Study Title

Chronic-dose Safety and Efficacy Study of a Bronchodilator Inhaler in Pediatric Asthmatics

Teva Identifier

IXR-303-25-167

ClinicalTrials.gov Identifier

NCT00308685

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Albuterol 90mcg | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations

Key Participation Requirements

Gender

Female, Male

Age Range

4 Years to 11 Years

Trial Duration

07/01/2007 - 01/00/1900

Phase

Phase 3

Study Type

Interventional